• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Sanofi

Headquarters: Paris, France
Website: https://www.sanofi.com/en
Year Founded: 1973
Status: Public
Industry Sector: HealthTechnology
CEO: Paul Hudson
Number Of Employees: 84,587
Enterprise Value: $133,819,673,907
PE Ratio: 20.19
Exchange/Ticker 1: Euronext Paris:SAN
Exchange/Ticker 2: NASDAQ:SNY
Latest Market Cap: $121,455,570,781

BioCentury | May 2, 2025
Finance

No follow-ons in April as drought crosses five-week threshold: Finance Report

Slow season continues for public offerings
Read More
BioCentury | May 2, 2025
Data Byte

Moderna’s May PDUFA date to offer next signal on FDA vaccine policy

A next-gen COVID vaccine among eight FDA decisions due in May
Read More
BioCentury | Apr 25, 2025
Finance

Pair of European start-ups launch with innovative antibodies: Finance Report

Plus: Flagship unveils disease interception play Etiome; Verastem raises $75M PIPE; and more
Read More
BioCentury | Apr 21, 2025
Deals

Earendil, Velavigo out-license bispecifics to Western biopharmas: Deals Report

Plus: Oak Hill reviving Roche program for Angelman syndrome
Read More
BioCentury | Apr 18, 2025
Finance

New fund Alis offers struggling biotechs an off-ramp: Finance Report

Plus: Updates from Glycomine, Attovia, Thirtyfivebio, Heparegenix, Duality, Pelthos and Third Harmonic
Read More
BioCentury | Apr 7, 2025
Deals

Latest capsid deal gives a lifeline to Sangamo: Deals Report

Plus: Sanofi gains license to another Nurix program; Allakos takes Tang/Concentra buyout offer
Read More
BioCentury | Apr 4, 2025
Management Tracks

Ex-Dyne team members reconvene at Crescent

Plus: New staff at Neurocrine, Xaira and Dark Blue; Oz confirmed at CMS
Read More
BioCentury | Apr 4, 2025
Data Byte

FDA’s six new product approvals in March

First drug for Prader-Willi hyperphagia, first Xolair biosimilar
Read More
BioCentury | Apr 4, 2025
Data Byte

First PDUFA date missed on RFK Jr.’s watch

FDA has at least seven more target action dates coming up in April
Read More
BioCentury | Apr 1, 2025
Distillery Therapeutics

Nasal anti-CD3 mAb-mediated Treg induction for traumatic brain injury

Read More
Items per page:
1 - 10 of 7146